MAPT and Alzheimer disease: We have demonstrated their diverse regulatory abilities in AD progression, encompassing functions such as modulating the neuroimmune response, facilitating Aβ degradation, and influencing tau hyperphosphorylation, all of which are critically contribute to the brain damage and cognitive dysfunction.